Kexing Biopharm Expands Global Strategy at CPHI Frankfurt 2025 Event

Kexing Biopharm Showcases Global Strategy at CPHI Frankfurt 2025

From October 28 to 30, 2025, Kexing Biopharm made a significant impact at CPHI Frankfurt, which is recognized as one of the most influential pharmaceutical exhibitions globally. This event served as a critical venue for Kexing to display its diverse product portfolio and innovative solutions designed for international markets. The exhibition highlighted the company's dedication to advancing global health through quality medicines.

During the event, Kexing Biopharm's international business team engaged in fruitful discussions with a variety of industry stakeholders from different countries. These dialogues focused on various crucial topics, including product registration, market access, and localized collaboration strategies. Kexing's capacity to provide full-cycle pharmaceutical services—from active pharmaceutical ingredients (APIs) to finished dosage forms—was also on full display, underpinned by robust quality and regulatory frameworks that comply with international standards.

CPHI Frankfurt is not merely a platform for showcasing products and services but also acts as a vital nexus for exchanging industry information and resource integration. Kexing actively visited competitor stands, met with existing clients, and connected with potential partners to discuss emerging trends within the global pharmaceutical landscape and recent policy developments affecting overseas markets. This engagement not only enriches Kexing's knowledge base but also informs strategic decisions regarding overseas expansion.

In recent years, Kexing Biopharm has implemented a